Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Digital Pathology Market to Develop owing to Research-based Diagnosis for Lethal Diseases

Blog Description

In pathology, digitization offers a host of advantages. Digital images can be utilized to make primary diagnosis, to obtain a second opinion, for telepathology, quality assurance, archiving and sharing, image analysis, marketing and business purposes, education and conferencing, research and publications, and tracking. 

Digital pathology, a medical field that involves transferring and managing data obtained from pathology laboratories into the digital format, is relatively new. Nevertheless, with the rising adoption of digital pathology solutions, this market is expected to display a CAGR of 11.4% between 2015 and 2025.

Browse Full Global Digital Pathology Market Report with TOC :

Digital Pathology Solutions Advantageous for Cancer Research

The digital pathology market has been exhibiting growth due to several reasons. The increasing expenditures on cancer diagnostics due to the rising number of cancer cases reported each year worldwide are favoring the need for digital solutions. This is because results of investigations and intermediate findings if digitized can be used later for research purposes. Increasing investments in healthcare IT and the close association between pathologists and cloud service companies to enable faster decisions are also fostering the growth of the global digital pathology market.

In pathological investigations, digitization allows better interoperability and reliable outcomes for pathologists which is why its adoption is on the rise in modern healthcare settings. The need for integrated modules of digital pathology and the rising need for automation in diagnostic procedures are estimated to further bolster the demand for digital pathology solutions in diagnostic laboratories and research institutions.

However, the development of the digital pathology market is hampered by certain factors. The high capital required for the installation of digital pathology frameworks and stringent regulations to adhere to for the use of digital pathology systems for primary diagnosis are slowing down the market’s growth.

Newer Version of Digital Pathology Viewer, Zoom, offers Added Benefits to Researchers

In a recent industry development, microDimensions has released version 2.0 of a free digital pathology viewer called Zoom. The upgraded version is the result of collaboration between researchers working independently on digital whole slide images. Version 2.0 allows loading and viewing of a sequence of images that were previously aligned and have been developed with other software applications. It also allows two aligned images to be viewed at the same time. For instance, to compare how tumors respond to different biomarkers.

The annotation functionality of Zoon 2.0 offers the possibility to label areas of interest, include comments, and share with others. These annotations can be copied to a series of other images for easy editing and comparison.

Browse the full Press Release of Global Digital Pathology Market at

Key Products Driving Growth in Digital Pathology Market

The product segments of the digital pathology market are software, hardware (scanners), and scanners. Scanners further comprise fluorescent scanners and bright field scanners. The sub-segments of the software segment are digital pathology systems and image analysis. In the software segment, image analysis is expected to register a 9.2% CAGR from 2015 and 2025 and dominate during this period. The service segment is further sub-segmented into consulting services, installation and integration services, and maintenance services; of these, the installation and integration sub-segment will register the fastest CAGR of 13.6% from 2015 to 2025.

The top players that are actively involved in the global digital pathology market are Perkin Elmer Inc., Sectra AB, GE Healthcare, Ventana Medical Systems Inc., Hamamatsu Photonics K.K., Olympus Corporation, MedImmune LLC, Koninklijke Philips N.V., Inspirata Co., Leica Biosystems, 3D-Histech Ltd., Digipath Co., Yokogawa Electronic Corporation, and ZEISS.